OrganOx

OrganOx develops the metra system, a normothermic machine perfusion (NMP) platform that perfuses donor livers with oxygenated blood-based perfusate at body temperature outside the body, so clinicians can assess organ viability before transplant. The company was spun out of the University of Oxford in 2008 and states that it joined Terumo Group in 2026.

Its customers are clinicians and transplant centers. The website describes metra as a way for transplant teams to extend preservation time, plan surgeries and assess marginal organs. The website does not describe pricing or the commercial model in detail.

Milestones on the website include a CE mark for metra in 2016 and FDA approval for liver transplants in the U.S. in 2021. Job postings list locations in Oxford, England and Madison, New Jersey, with 22 open roles across engineering, regulatory, clinical, quality and commercial functions.

Product: OrganOx metra, a normothermic machine perfusion system for liver transplantation, with an on-board oxygenator, pumps, blood gas analyzer and touchscreen.